Document Detail

Polybrominated diphenyl ethers (PBDEs) in marine foodstuffs in Australia: Residue levels and contamination status of PBDEs.
MedLine Citation:
PMID:  21719040     Owner:  NLM     Status:  Publisher    
Edible marine products (n=24) collected from the fish markets in Adelaide, Australia, were analysed for the presence of polybrominated diphenyl ethers (PBDEs). The total concentration of 11 PBDE congeners found in the marine products ranged from 1.01 to 45ng/g fresh weight. Among the samples analysed, imported silver fish and prawns from Vietnam and Thailand respectively, recorded the highest ∑PBDEs concentrations (45.10 and 43.29ng/g fresh weight) as against 13.08 and 12.57ng/g fresh weight in Australian king prawns and Gar fish. BDE-209 was the most dominant congener in the marine products followed by BDE-47, 99 and 100. The calculated average daily intakes of ∑PBDEs per day for an adult male and female (19 or more years old) were 1026.8 and 1188.4ng/kg per day, respectively. This study clearly shows that the dietary exposure to marine foods can contribute to PBDEs accumulation in human body.
Devarajan Shanmuganathan; Mallavarapu Megharaj; Zuliang Chen; Ravi Naidu
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-6-28
Journal Detail:
Title:  Marine pollution bulletin     Volume:  -     ISSN:  1879-3363     ISO Abbreviation:  -     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-7-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0260231     Medline TA:  Mar Pollut Bull     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011. Published by Elsevier Ltd.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A quantification of the standing stock of macro-debris in Majuro lagoon and its effect on hard coral...
Next Document:  Prevalence of target organ damage and metabolic abnormalities in resistant hypertension.